New World Medical announces launch date of Streamline Surgical System
The Streamline Surgical System (New World Medical) will have full commercial availability on April 1, 2022, according to a company press release.
The single-use device, featuring ClickPulse Technology, is a first-line implant-free system designed to create precise goniotomies in the trabecular meshwork and deliver small amounts of ophthalmic viscosurgical device into the canal of Schlemm in 1 unified step.
Streamline received 510k clearance from the FDA in October 2021.
“Since gaining FDA clearance in October, we have been working hard to prepare for full commercialization of Streamline. We are pleased with the initial surgeon feedback, which has validated the need for a precise, implant-free, and minimally invasive surgical option. With full commercial availability scheduled for April 1, 2022, and Phase 4 studies in progress, Streamline is positioned to become a compelling addition to our portfolio of innovative surgical products that benefit both patients and surgeons,” said Raymond Kong, Chief Commercial Officer of New World Medical in the press release.
